Hematology/Oncology

Top Story

Molecular similarities discovered among endometrial cancers

July 28, 2017

Clear cell endometrial cancer appeared to have molecular similarities with serous endometrial cancer and endometrioid endometrial cancer, according to a study published in Cancer.

Additionally, researchers reported that TAF1 appears to be a driver mutated gene in clear cell endometrial cancer (CCEC).

Debate, fluidity continues over repeal, replacement of ACA

July 27, 2017
The United States Senate is more than halfway through 20 hours of debate over the so-called “skinny repeal” bill that would start the process of eliminating…
In the Journals

Renal transplant recipients at greater risk for melanoma

July 27, 2017
Renal transplant recipients had a greater risk than the general population for melanoma, according to recently published study results in JAMA Dermatology. Researchers…
Meeting News

Guest Commentary: Debu Tripathy, MD, reviews highlights in breast cancer from ASCO 2017

July 27, 2017
In this guest commentary, Debu Tripathy, MD, professor and chair of the department of breast medical oncology at The University of Texas MD Anderson Cancer Center and a

AstraZeneca, Merck to collaborate on olaparib development

July 27, 2017
AstraZeneca and Merck entered a global strategic collaboration to develop and commercialize olaparib to treat multiple malignancies. Olaparib (Lynparza, AstraZeneca)…
More Headlines »
CME

Combination Strategies in Melanoma Management: What’s New and What’s Next

This activity is supported by an educational grant from Genentech, Inc.

Melanoma is the sixth most common cancer in the United States and the deadliest form of skin cancer. Although it is…
More »
Video
Meeting News

VIDEO: Genomic risk system may help treat prostate cancer

July 19, 2017
More »
Resource Centers
Biosimilars in the US

Biosimilars in the US

CME

Hot Topics in Metastatic Breast Cancer Management: Clinical Advances with CDK4/6 Inhibitors

This activity is supported by an educational grant from Novartis Pharmaceuticals Corporation.

While the mortality rates for advanced or metastatic breast cancer (MBC) have steadily decreased, in part due to…
More »
Current Issues
View the Current Issue
HemOnc Today
Advertisement
Advertisement